Farmer, C. A., Thurm, A., Farhat, N., Bianconi, S., Keener, L. A., & Porter, F. D. (2019). Long-term neuropsychological outcomes from an open-label phase 1/2a trial of 2-hydoxypropyl-β-cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1. CNS Drugs.
Chicago Style CitationFarmer, Cristan A., Audrey Thurm, Nicole Farhat, Simona Bianconi, Lee Ann Keener, and Forbes D. Porter. "Long-term Neuropsychological Outcomes From an Open-label Phase 1/2a Trial of 2-hydoxypropyl-β-cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1." CNS Drugs 2019.
MLA CitationFarmer, Cristan A., et al. "Long-term Neuropsychological Outcomes From an Open-label Phase 1/2a Trial of 2-hydoxypropyl-β-cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1." CNS Drugs 2019.